- Todos > Quality and Safety: Medicines > Quality Assurance
- Todos > Quality and Safety: Medicines > Regulatory Support
- Palabras clave > compliance testing
- Palabras clave > drug testing
- Palabras clave > pharmaceutical quality control
- Palabras clave > quality assurance - medicines
- Palabras clave > quality assurance system
- Palabras clave > quality of medicines
- Palabras clave > quality tests - medicines
- Palabras clave > sampling and testing - medicines
- Palabras clave > sampling studies
- Palabras clave > substandard drugs
(2011; 48 pages)
The Afghanistan Ministry of Public Health (MoPH), with technical assistance from the Strengthening Pharmaceutical Systems (SPS) Program, carried out a survey of medicines quality in Afghanistan. The survey was conducted for the MoPH to determine whether medicines in the public and private sectors of Afghanistan comply with established international pharmacopeial standards. The findings of this quantitative survey, together with the findings of a separately conducted qualitative medicines quality assurance assessment survey in Afghanistan, will lead to the development of policies and strategies for a sustainable medicines quality assurance system for the country...
Substandard products are found in both the public (government and donor-supported) and the private (for-profit) sectors. Findings relate primarily to the better regulated segment of the Afghanistan pharmaceutical market but measures are still needed to reduce the observed 9 percent test failure rate. A comprehensive but realistic and sustainable strategy is needed to assure the quality of medicines in Afghanistan.